techcentury.com
Esperion Provides Drug Development Update, Financial Results
ANN ARBOR — Esperion Therapeutics Inc. (NASDAQ:ESPR), the pharmaceutical startup working on a new class of cholesterol-reducing drugs, provided a drug development update and financial results…